Maggi C A
Pharmacology Dept, A. Menarini Pharmaceuticals, Florence, Italy.
Eur Respir J. 1993 May;6(5):735-42.
The mammalian tachykinins (TKs), substance P and neurokinin A, are present in sensory nerve fibres in the upper and lower airways of various mammalian species, including humans. TKs are released from these afferent nerves in an "efferent" mode at peripheral level, especially in response to irritant stimuli. TKs exert a variety of biological effects (bronchoconstriction, plasma protein extravasation, stimulation of mucus secretion), collectively known as "neurogenic inflammation", and this process is thought to be of potential pathogenic relevance for various airway diseases. The recent development of potent and selective TK receptor antagonists on the one hand provides important new tools for the understanding of basic airway physiology and pathophysiology and, on the other, opens new possibilities for therapy of airway diseases.
哺乳动物速激肽(TKs),即P物质和神经激肽A,存在于包括人类在内的各种哺乳动物物种的上、下呼吸道的感觉神经纤维中。TKs在外周水平以“传出”模式从这些传入神经释放,尤其是对刺激性刺激的反应。TKs发挥多种生物学效应(支气管收缩、血浆蛋白外渗、黏液分泌刺激),统称为“神经源性炎症”,并且该过程被认为与各种气道疾病具有潜在的致病相关性。强效和选择性TK受体拮抗剂的最新进展一方面为理解气道基本生理学和病理生理学提供了重要的新工具,另一方面为气道疾病的治疗开辟了新的可能性。